Ncage TherapeuticsS.A.Active

Research and experimental development on biotechnology

KRS: 0001118242 NIP: 6762574004 REGON: 38487614000000

Overview

Registry date
2024-07-25
Share capital
$31,564.02
Activity description

Ncage Therapeutics is developing synthetic protein cages based on the bacterial TRAP protein, which can display biological material or transport molecules like nucleic acids and proteins into cells. Their platform includes programmable opening and closing features for loading and releasing cargo, such as proteins and small molecule drugs. The company focuses on applications in synthetic viral-like particle vaccines and enhancing the safety profile of antibody-drug conjugates for cancer treatment.

Registered address
Ul. Profesora Michała Bobrzyńskiego 14, 30-348 Kraków, Poland
Website
ncage.orgWebsite active
Electronic delivery address
AE:PL-22919-56200-ASEAV-28

Industry

NameCode
Research and experimental development on biotechnology
72.11.Z
Manufacture of basic pharmaceutical products
21.10.Z
Manufacture of other chemical products n.e.c.
20.59.Z
Other research and experimental development on natural sciences and engineering
72.19.Z
Other professional, scientific and technical activities not elsewhere classified
74.90.Z

Accounts

Registered as a VAT taxpayer on 2021-03-01.Active

Authorized Representatives

Ownership

Competitors

NameRevenueWebsite
UveraS.A.$155,384.29uvera.eu
PellicarnosS.A.$135,043.43pellicarnos.com
IntelliseqS.A.$111,419.60intelliseq.pl
WPD PharmaceuticalsS.A.$87,561.70wpdpharmaceuticals.pl/contact/wpdsa/
DigitmedS.A.$64,087.41digitmed.pl
InventroS.A.$12,176.61inventro.co
Oncotherics PolandS.A.$7,565.33oncotherics.com
ArthecS.A.$6,901.64arthec.eu
4cell TherapiesS.A.$838.644celltherapies.com
UrtesteS.A.$324.85urteste.com

FAQ

Last updated: 2025-12-15